Biological sample collection kits market seen reaching $19.26B by 2030

The biological sample collection kits market is projected to grow from $11.39 billion in 2025 to $19.26 billion by 2030, according to a new Business Research Company report. Demand is being driven by infectious disease testing, genomics, home collection kits and broader use in clinical research and chronic disease screening.

Why it matters: - Biological sample collection kits support diagnosis, monitoring and research by helping preserve blood, saliva, urine and tissue samples safely. - The market’s growth points to rising demand for at-home testing, remote collection and more standardized specimen handling across healthcare and research. - Higher kit adoption can improve sample integrity, speed testing workflows and expand access to diagnostics.

What happened: - The Business Research Company released a report on the global biological sample collection kits market on July 28, 2026. - The report estimates the market will rise from $11.39 billion in 2025 to $12.78 billion in 2026. - The report projects the market will reach $19.26 billion by 2030. - The forecast implies a 10.8% compound annual growth rate through 2030.

The details: - Biological sample collection kits are specialized tools for collecting, preserving and transporting biological specimens. - The kits typically include sterile containers, swabs and preservatives. - The report links near-term growth to infectious disease testing initiatives, expanded testing capacity at hospitals and diagnostic centers, and early adoption of standardized swab and viral transport medium kits. - The report also points to growth in clinical research and greater awareness of safe specimen handling protocols. - Longer-term demand is expected to come from homecare and self-collection kits, DNA and RNA collection kits used in genomics, and blood and saliva kits used for chronic disease detection and screening programs. - Biobanking, longitudinal cohort studies and remote sample collection are also expected to add demand. - The report says users are prioritizing kits that are user-friendly and stable during transport. - The report highlights wider use of swabs, viral transport medium and blood kits in clinical settings. - The report includes market coverage for Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region over the forecast period.

Between the lines: - The market outlook tracks a broader shift toward decentralized testing and more frequent sample collection outside traditional labs. - Infectious disease pressure remains a key demand driver, with the CDC reporting a 16% increase in U.S. tuberculosis cases from 2022 to 2023, reaching 9,615 cases. - The CDC also reported the incidence rate rose from 2.5 to 2.9 per 100,000 people, with increases among Hispanic and Black populations within non-U.S.-born groups. - That pattern suggests collection tools will stay central to surveillance, screening and public health response.

What's next: - The Business Research Company says future market growth will likely be shaped by more remote collection, broader genomics use and expanded chronic disease screening. - The company also says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspot infographics and future trend analysis. - The full report is available here. - A free sample is available here.

The bottom line: - Biological sample collection kits are moving from a niche lab supply to a growth market tied to testing, genomics and home-based healthcare.